Pharmacokinetic studies of a novel tubulin inhibitor SK1326 in Rat Plasma by UPLC-MS/MS.
A sensitive method for quantitation of SK1326 in rat plasma has been established using ultra performance liquid chromatography-electrospray ionization tandem mass spectrometry (UPLC-ESI/MS/MS). SK1326 and internal standard (tramadol) in plasma sample was extracted using acetonitrile. A centrifuged upper layer was then evaporated and reconstituted with the mobile phase of 0.5% formic acid-acetonitrile (35:65, v/v). The reconstituted samples were injected into a C18 reversed-phase column. Using MS/MS in the multiple reaction monitoring (MRM) mode, SK1326 and tramadol were detected without severe interference from rat plasma matrix. SK1326 produced a protonated precursor ion ([M+H]+ ) at m/z 432.3 and a corresponding product ion at m/z 114.4. And the internal standard produced a protonated precursor ion ([M+H]+ ) at m/z 264.4 and a corresponding product ion at m/z 58.1. Detection of SK1326 in rat plasma by the UPLC-ESI/MS/MS method was accurate and precise with a quantitation limit of 1.0 ng/mL. The validation, reproducibility, stability, and recovery of the method were evaluated. The method has been successfully applied to pharmacokinetic studies of SK1326 in rat plasma. Pharmacokinetic parameters of SK1326 was evaluated after intravenous (i.v.; at doses of 10 mg/kg) and oral (p.o.; at doses of 20 mg/kg) administration of SK1326 in rats. After p.o. administration (20 mg/kg) of SK1326, F (Fraction absorbed) value was approximately 77.1%.